Episode 177: steroids and CV risk, dementia guideline, fezolinetant for VMS, and osteoporosis screening

This week Gary, Mark, Kate and Henry discuss: adverse effects from inhaled steroids in asthma, Italian dementia guideline, fezolinetant for treatment of vasomotor symptoms, and updated USPSTF recommendations for osteoporosis screening.

Show notes and links:

Asthma and risk of CV events: https://pubmed.ncbi.nlm.nih.gov/39088770/

GINA 2024 guidelines: https://ginasthma.org/2024-report/

Italian dementia guidelines: https://www.ncbi.nlm.nih.gov/pubmed/39544104 with link to full report in Inglese: https://www.iss.it/documents/d/guest/the-full-guideline-english-version

Fezolinetant for vasomotor symptoms: https://pubmed.ncbi.nlm.nih.gov/39557487/

USPSTF osteoporosis screening guideline: https://pubmed.ncbi.nlm.nih.gov/39808425/

Dietary assessment tool: https://epi.grants.cancer.gov/asa24/

Article on interval for next BMD screening based on initial result: https://pubmed.ncbi.nlm.nih.gov/22256806/